Filter
552
Filtered Results: 552
Text search:
Clinical
characterization
Featured
Recommendations
57
New Publications
88
Language
Document type
No document type
180
Guidelines
134
Studies & Reports
133
Manuals
41
Strategic & Response Plan
28
Fact sheets
25
Situation Updates
7
Training Material
3
Resource Platforms
1
Countries / Regions
Global
26
India
23
Latin America and the Carribbean
21
Africa
16
Brazil
11
Kenya
9
Nigeria
9
Western and Central Europe
9
South Africa
9
Russia
8
Colombia
7
Germany
6
Middle East and North Africa
6
Uganda
6
Namibia
6
Liberia
6
Sierra Leone
5
West and Central Africa
5
Zambia
5
Venezuela
4
Tanzania
4
Western Pacific Region
4
Eastern Europe and Central Asia
4
East and Southern Africa
4
Ghana
3
Rwanda
3
Syria
3
Zimbabwe
3
Philippines
3
Mozambique
3
Angola
3
Tajikistan
2
Chile
2
Cameroon
2
Burkina Faso
2
Malawi
2
Guinea
2
USA
2
Congo, Democratic Republic of
2
South–East Asia Region
2
France
2
Argentina
2
Bangladesh
2
Eastern Europe
2
Yemen
2
Pakistan
2
Nepal
1
Ukraine
1
Lesotho
1
Turkey
1
Benin
1
Afghanistan
1
Peru
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Jordan
1
North America
1
Portugal
1
Bolivia
1
Vietnam
1
Sudan
1
Ethiopia
1
South Sudan
1
Indonesia
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
148
Clinical Guidelines
57
Public Health
31
Pharmacy & Technologies
20
Key Resources
13
Women & Child Health
9
Capacity Building
4
Toolboxes
COVID-19
112
Rapid Response
59
NTDs
54
AMR
52
HIV
20
TB
19
Mental Health
18
Pharmacy
18
Ebola & Marburg
17
Planetary Health
14
Zika
12
NCDs
9
Disability
5
Cholera
5
Caregiver
5
Specific Hazards
4
Refugee
4
Malaria
4
Natural Hazards
3
Conflict
3
Health Financing Toolbox
2
Polio
2
Global Health Education
2
This is the 42nd situation report for the multi-country outbreak of mpox, which provides an update on the epidemiological situation of mpox in Africa (including countries in the WHO African Region and some countries in the WHO Eastern Mediterranean Region), with data as of 3 November 2024.
Int J Health Geogr. 2002; 1: 5.
Published online 2002 Dec 20. doi: 10.1186/1476-072X-1-5
PMCID: PMC149400
PMID: 12537588
This resource pack was developed for the country offices of the World Health Organization and national Public Health institutions, as an overview of the key information needed for advising their Member States in response to questions raised on human health due to influenza outbreaks or detections in...
In aquaculture, antibiotics have been used mainly for therapeutic purposes and as prophylactic agents. The contribution to antimicrobial resistance of antibiotics used in aquaculture is reviewed here, using a risk analysis framework. Some recommendations on responsible conduct in this context are pr...
The World Health Organization Disability Assessment Schedule (WHODAS 2.0) is a generic assessment instrument developed by WHO to provide a standardized method for measuring health and disability across cultures. It was developed from a comprehensive set of International Classification of Functioning...
Mood disorders
Chapter E.2
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i...
The WHO country office for Ghana, began the year 2019 with a 4-day staff retreat at the Busua Beach Resort in the Western Region from 04 to 08 March 2019. The theme for the retreat was ‘Impacting the Health and Lives of the people of Ghana through the Triple Billion Goal”. The staff outlined pri...
Glob Heart . 2020 Oct 13;15(1):69. doi: 10.5334/gh.891.
This manual summarizes the methodology used to develop WHODAS 2.0 and the findings obtained when the schedule was applied to certain areas of general health, including mental and neurological disorders.
The manual will be useful to any researcher or clinician wishing to use WHODAS 2.0 in their prac...
The key areas covered are diagnosis, imaging, pathology, surgery, rehabilitation, palliative care and survivorship. It emphasizes a multi-disciplinary team approach which is paramount for quality cancer care. The specific cancers covered are breast, central nervous system, gastroint...
Pandemic Influenza Risk Management
recommended
A WHO guide to inform & harmonize national & international pandemic preparedness and response
The main updates from the 2013 interim guidance are:
Alignment with other relevant United Nations policies for crisis and emergency management, and
Inclusion of the significant development in re...
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
This document compiles the recommendations made by the World Health Organization (WHO) and the Pan American Health Organization (PAHO) to help professionals in charge of vector control programs in Latin America and the Caribbean at the national, subnational, and local level update their knowledge in...
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...
Early detection, assessment and response to acute public health events:
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
